Emerging targets and potential therapeutic agents in non-alcoholic fatty liver disease treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emerging targets and potential therapeutic agents in non-alcoholic fatty liver disease treatment

Published:2020-07 Issue: Volume:197 Page:112311
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Yang Yu,Zhao Yu,Li Wenzhen,Wu Yuyao,Wang Xin,Wang Yijie,Liu Tingmei,Ye Tinghong,Xie Yongmei,Cheng Zhiqiang,He Jun,Bai Peng,Zhang Yiwen,Ouyang Liang

Funder

National Natural Science Foundation of China

Chengdu Science and Technology Bureau

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference303 articles.

1. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease;Gaggini;Nutrients,2013

2. World Gastroenterology Organisation global guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitis;LaBrecque;J. Clin. Gastroenterol.,2014

3. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

4. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association;Chalasani;Am. J. Gastroenterol.,2012

5. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies;Singh;Clin. Gastroenterol. Hepatol.,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic targets for metabolic dysfunction-associated steatotic liver disease and their roles in hepatocellular carcinoma;Exploration of Digestive Diseases;2023-12-13

2. Design, synthesis, and biological studies of novel sulfonamide derivatives as farnesoid X receptor agonists;European Journal of Medicinal Chemistry;2023-10

3. Emerging Therapies and Therapeutic Targets for Composite Liver Disease: NASH;Current Topics in Medicinal Chemistry;2023-08

4. Metabolomic analysis identifies the regulation of lipid metabolism pathway as potential mechanisms of Jiangzhi decoction against non-alcoholic fatty liver disease;Journal of Pharmacy and Pharmacology;2023-07-19

5. Discovery and development of palmatine analogues as anti-NASH agents by activating farnesoid X receptor (FXR);European Journal of Medicinal Chemistry;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3